ADRIENNE BROUSSARD: Open Payments
NPI 1326763228 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 30 payments from 8 companies in 2025. Trend: 2023 $703 · 2024 $347 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $251 |
| Optinose US, Inc. | 7 | $132 |
| ABBVIE INC. | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| GENZYME CORPORATION | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $17 |
Products named: NUCALA, Xhance, DUPIXENT, RINVOQ, Sunosi, UBRELVY, QULIPTA, LUMRYZ.
Industry payments across LA — which companies pay providers there.
